Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Real‐world outcomes of FOLFIRINOX vs gemcitabine and nab‐paclitaxel in advanced pancreatic cancer: A population‐based propensity score‐weighted analysis

PaperCitations, authors & open-access status

Real‐world outcomes of FOLFIRINOX vs gemcitabine and nab‐paclitaxel in advanced pancreatic cancer: A population‐based propensity score‐weighted analysis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 91 citations, 2019 year and gold oa status.

91
Citations
2019
Year
gold
OA Status

Related on ScholarIQ

Erin Kennedy
Author
Cancer Medicine
Journal
Pancreatic and Hepatic Oncology Research
Topic
Pancreatic and Hepatic Oncology Research
Topic
Neutropenia and Cancer Infections
Topic
Economic and Financial Impacts of Cancer
Topic
470M+ articles · free account